Výsledky vyhledávání - "Reporting System"

Akademický článek

eXtensible Business Reporting Language Data Assurance Challenges and Strategic Approaches: A Study in the Malaysian Business Reporting System Context.

Autor: Mohaidin, Nur Jannah¹ P103243@siswa.ukm.edu.my, Aman, Aini² aini@ukm.edu.my, Ilias, Azleen³ azleens@uniten.edu.my, Keliwon, Kamarul Baraini⁴ baraini@ukm.edu.my, Hassan, Haslina⁵ haslina.hassan@unikl.edu.my

Publikováno v: Journal of Information Technology Management (JITM). 2024, Vol. 16 Issue 3, p173-191. 19p.

Zobrazit plný text záznamu

Akademický článek

Real-world study of adverse events associated with triptan use in migraine treatment based on the U.S. Food and Drug Administration (FDA) adverse event reporting system (FAERS) database

Autor: Wen-Hui Liu, Hui-Min Hu, Chen Li, Qing Shi, Chun-Hua Liu, An-Xiang Liu, Yi-Fan Li, Yi Zhang, Peng Mao, Bi-Fa Fan

Publikováno v: The Journal of Headache and Pain, Vol 25, Iss 1, Pp 1-17 (2024)

Abstract Background Triptans selectively agoniste 5-Hydroxytryptamine(5-HT) receptors and are widely used in the treatment of migraine. Nevertheless, there is a dearth of comprehensive real-world clinical research on the safety of triptans. In light

Externí odkaz: https://doaj.org/article/65851d866a4644209009a8dfc2df51ad

Zobrazit plný text záznamu

Akademický článek

Association of incretin-based therapies with hepatobiliary disorders among patients with type 2 diabetes: a case series from the FDA adverse event reporting system

Autor: Yankun Liang, Zhenpo Zhang, Jingping Zheng, Yuting Wang, Jiaxin He, Juanzhi Zhao, Ling Su

Publikováno v: Endocrine Connections, Vol 13, Iss 12, Pp 1-10 (2024)

Aim: Incretin therapies, including dipeptidyl peptidase-4 inhibitors (DPP-4is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs), are crucial for type 2 diabetes treatment. Evidence of their association with gallbladder, biliary diseases, and

Externí odkaz: https://doaj.org/article/6d73d621ce374d4eb5999ecb8e5d8476

Zobrazit plný text záznamu